» Articles » PMID: 25111321

Is Increased Susceptibility to Balkan Endemic Nephropathy in Carriers of Common GSTA1 (*A/*B) Polymorphism Linked with the Catalytic Role of GSTA1 in Ochratoxin a Biotransformation? Serbian Case Control Study and in Silico Analysis

Overview
Journal Toxins (Basel)
Publisher MDPI
Specialty Toxicology
Date 2014 Aug 12
PMID 25111321
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Although recent data suggest aristolochic acid as a putative cause of Balkan endemic nephropathy (BEN), evidence also exists in favor of ochratoxin A (OTA) exposure as risk factor for the disease. The potential role of xenobiotic metabolizing enzymes, such as the glutathione transferases (GSTs), in OTA biotransformation is based on OTA glutathione adducts (OTHQ-SG and OTB-SG) in blood and urine of BEN patients. We aimed to analyze the association between common GSTA1, GSTM1, GSTT1, and GSTP1 polymorphisms and BEN susceptibility, and thereafter performed an in silico simulation of particular GST enzymes potentially involved in OTA transformations. GSTA1, GSTM1, GSTT1 and GSTP1 genotypes were determined in 207 BEN patients and 138 non-BEN healthy individuals from endemic regions by polymerase chain reaction (PCR). Molecular modeling in silico was performed for GSTA1 protein. Among the GST polymorphisms tested, only GSTA1 was significantly associated with a higher risk of BEN. Namely, carriers of the GSTA1*B gene variant, associated with lower transcriptional activation, were at a 1.6-fold higher BEN risk than those carrying the homozygous GSTA1*A/*A genotype (OR = 1.6; p = 0.037). In in silico modeling, we found four structures, two OTB-SG and two OTHQ-SG, bound in a GSTA1 monomer. We found that GSTA1 polymorphism was associated with increased risk of BEN, and suggested, according to the in silico simulation, that GSTA1-1 might be involved in catalyzing the formation of OTHQ-SG and OTB-SG conjugates.

Citing Articles

Upregulation of Hepatic Glutathione S-Transferase Alpha 1 Ameliorates Metabolic Dysfunction-Associated Steatosis by Degrading Fatty Acid Binding Protein 1.

Jiang J, Li H, Tang M, Lei L, Li H, Dong B Int J Mol Sci. 2024; 25(10).

PMID: 38791126 PMC: 11120891. DOI: 10.3390/ijms25105086.


A case-control study and systematic review of the association between glutathione S-transferase genes and chronic kidney disease.

Peng J, Ma P, Wu X, Yang T, Hu Y, Xu Y Heliyon. 2023; 9(11):e21183.

PMID: 37920524 PMC: 10618768. DOI: 10.1016/j.heliyon.2023.e21183.


rs8177412 Polymorphism Modifies Risk of Upper Urothelial Tumors in Patients with Balkan Endemic Nephropathy.

Radic Savic Z, Coric V, Vidovic S, Vidovic V, Becarevic J, Milovac I Medicina (Kaunas). 2023; 59(8).

PMID: 37629712 PMC: 10456338. DOI: 10.3390/medicina59081421.


Toxin Degradation by Rumen Microorganisms: A Review.

Loh Z, Ouwerkerk D, Klieve A, Hungerford N, Fletcher M Toxins (Basel). 2020; 12(10).

PMID: 33092236 PMC: 7590051. DOI: 10.3390/toxins12100664.


Association of SOD2 (rs4880) and GPX1 (rs1050450) Gene Polymorphisms with Risk of Balkan Endemic Nephropathy and its Related Tumors.

Dragicevic B, Suvakov S, Jerotic D, Reljic Z, Djukanovic L, Zelen I Medicina (Kaunas). 2019; 55(8).

PMID: 31382611 PMC: 6723896. DOI: 10.3390/medicina55080435.


References
1.
Buzio L, De Palma G, Mozzoni P, Tondel M, Buzio C, Franchini I . Glutathione S-transferases M1-1 and T1-1 as risk modifiers for renal cell cancer associated with occupational exposure to chemicals. Occup Environ Med. 2003; 60(10):789-93. PMC: 1740386. DOI: 10.1136/oem.60.10.789. View

2.
Stander M, Steyn P, van der Westhuizen F, Payne B . A kinetic study into the hydrolysis of the ochratoxins and analogues by carboxypeptidase A. Chem Res Toxicol. 2001; 14(3):302-4. DOI: 10.1021/tx000221i. View

3.
Ping J, Wang H, Huang M, Liu Z . Genetic analysis of glutathione S-transferase A1 polymorphism in the Chinese population and the influence of genotype on enzymatic properties. Toxicol Sci. 2005; 89(2):438-43. DOI: 10.1093/toxsci/kfj037. View

4.
Meki A, Hussein A . Melatonin reduces oxidative stress induced by ochratoxin A in rat liver and kidney. Comp Biochem Physiol C Toxicol Pharmacol. 2001; 130(3):305-13. DOI: 10.1016/s1532-0456(01)00248-4. View

5.
Cavin C, Delatour T, Marin-Kuan M, Holzhauser D, Higgins L, Bezencon C . Reduction in antioxidant defenses may contribute to ochratoxin A toxicity and carcinogenicity. Toxicol Sci. 2006; 96(1):30-9. DOI: 10.1093/toxsci/kfl169. View